Industry & Business

Fusion Antibodies Doubling Workforce as it Targets Global Business

 Breaking News
  • Aramark’s Frank Gleeson Named European Industry Leader of the Year Frank Gleeson, president of Aramark Northern Europe, has been named the 2018 NACS European Industry Leader of the Year. The award, sponsored by Mondelēz International, was presented during the recent NACS Convenience Summit Europe in London. “I cannot think of a better leader to be recognised for this prestigious award. He has been one of the industry’s strongest advocates for [...]...
  • McAleer & Rushe Recognised at the Irish Construction Industry Awards Gala Northern Ireland-based developer and contractor McAleer & Rushe has been awarded the prize for ‘International Project of the Year’ at the Irish Construction Industry Awards for Global Student Accommodation’s 1000-bed Catherine House scheme in Portsmouth. The awards, now in their fifth year, recognise companies which demonstrate excellence and innovation in Ireland’s construction industry. McAleer & [...]...
  • Bord Bia’s 2018 Brexit Barometer Results The Minister for Agriculture, Food and the Marine Michael Creed TD has launched the Bord Bia 2018 Brexit Barometer, a comprehensive survey of 117 Irish food, drink and horticulture companies, representing 48% of the sector’s exporters to the United Kingdom. Over 100 senior industry representatives attended the launch in Bord Bia to hear the report findings. The purpose [...]...
  • College Group to Construct New €10 Million Biofuel Facility in County Meath College Group is to invest €10 million in building a new renewable energy facility producing biofuel from used cooking oil and animal fats in north County Meath. The investment is supported by the Irish government through Enterprise Ireland. The new 25 million litre purpose-built plant will be set on a 47.5 acre site and will [...]...
  • Irish Global Packaging Solutions Company Announces €27 Million Investment Zeus, the Irish-owned global packaging solutions company, has announced a €27 million investment in new premises in Dublin and the UK. The investment will also lead to the creation of 80 jobs. An investment of €15 million will see Zeus’ Dublin presence double in size to 250,000 sq ft, with the creation of 50 new jobs. Zeus [...]...

Fusion Antibodies Doubling Workforce as it Targets Global Business

Fusion Antibodies Doubling Workforce as it Targets Global Business
May 28
10:36 2018

Belfast-based Clinical Research firm, Fusion Antibodies has announced plans to create 28 new jobs. This recruitment drive, supported by Invest Northern Ireland, will help Fusion deliver its services to its growing international customer base.

The company’s antibody engineering technology assists in the development of novel biological molecules that are used as innovative drugs for human diseases including cancer, coeliac disease, chronic fungal infections and immunological indications.

Announcing the expansion, Paul Kerr, Managing Director of Fusion Antibodies, said: “Invest NI continues to provide excellent support as we look to expand the business rapidly and to capitalise on our position as a successful international CRO providing a range of antibody engineering services. The work to more than double the capacity of our laboratory and office space is expected to be completed by the end of the summer, ahead of our original schedule. The new employees will include technically skilled staff working to deliver our current services to biopharma companies.

“We are also recruiting scientists with specialised skills to work in our new product development team on the establishment of our antibody affinity maturation service and the creation of a mammalian antibody library. In addition, our growth strategy, focussed on reinvigorating and expanding our new business development and sales function, will benefit from further resource in this area.”

Invest NI has offered Fusion Antibodies £213,000 towards its job creation and marketing activities.

Grainne McVeigh, Invest NI’s Director of Life Sciences, said: “This expansion is an exciting milestone for Fusion Antibodies which is among a dynamic group of companies contributing to our growing Life and Health Sciences sector. Invest NI has been working alongside the business for many years and we are delighted to be helping Fusion Antibodies to scale up its workforce and target market opportunities with drug development and diagnostics companies across the globe.”

CAPTION:

Pictured (L-R): Grainne McVeigh, Director of Life Sciences, Invest Northern Ireland, and Paul Kerr, Managing Director of Fusion Antibodies.

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4